Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome?
about
Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study designPromoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases.Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells.Role of Mir-155 in Controlling HIF-1α Level and Promoting Endothelial Cell Maturation.Identical effects of VEGF and serum-deprivation on phenotype and function of adipose-derived stromal cells from healthy donors and patients with ischemic heart diseaseInfluence of patient related factors on number of mesenchymal stromal cells reached after in vitro culture expansion for clinical treatment.Mesenchymal stromal cell therapy in ischemic heart disease.The guidance of stem cell cardiomyogenic differentiation by bioartificial scaffolds mimicking myocardium structure and biomechanics.Bone marrow and adipose mesenchymal stem cells attenuate cardiac fibrosis induced by methotrexate in rats.Differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in fibrin scaffold by a histone deacetylase inhibitor.Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology.Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up.Multipotent bone marrow stromal cell therapy promotes endogenous cell proliferation following ischemic stroke.GATA-4-expressing mouse bone marrow mesenchymal stem cells improve cardiac function after myocardial infarction via secreted exosomes.
P2860
Q26822936-09B5D7F7-B834-430C-B9BB-DD7D11C4226AQ36117818-35CC8D08-3569-4B01-BDC4-D27359A151B0Q36733903-9D930830-06FD-4886-B9F8-B396B3D46137Q37330414-C1F1B172-BDAF-48FB-BA01-61AA35080A12Q37367626-96BBF692-130F-4F77-AA86-B762CF48E11BQ38664925-103A663F-8915-4BEC-8E87-13753FB48C61Q38886932-E6A23F46-E043-469A-B66B-FEA82783FF00Q46041822-D216C814-3F8A-4585-9E16-B8431D6ADBDFQ46255850-1748D7E8-7E25-4347-ACCB-7D33A82541BEQ47094938-B83B43FB-DA31-4960-8316-61B05505A1DFQ47642528-876D9241-D686-4C9F-A665-3159FD8279BBQ48459462-CAE86C49-0F2C-4BCE-9DE5-494D1894095DQ50951146-ACE32AAB-7404-4705-945A-38FDCEB1F558Q55277616-C363024D-B2A3-4D96-880E-8B3390A2B6F7
P2860
Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Stem cells therapy for cardiov ...... ct and secure optimal outcome?
@en
type
label
Stem cells therapy for cardiov ...... ct and secure optimal outcome?
@en
prefLabel
Stem cells therapy for cardiov ...... ct and secure optimal outcome?
@en
P2860
P1433
P1476
Stem cells therapy for cardiov ...... ct and secure optimal outcome?
@en
P2093
Jens Kastrup
P2860
P2888
P304
P356
10.1007/S13167-011-0062-5
P577
2011-02-08T00:00:00Z
P5875
P6179
1036021170